Endoxifen for breast cancer: Multiple-dose, dose-escalation study characterizing pharmacokinetics and safety in metastatic breast cancer patients.

被引：0
|
作者：
Ahmad, Ateeq
Sheikh, S.
Nagarkar, R.
Singh, J. K.
Krishnan, S.
Shrivastav, S.
Shetty, P.
Kale, P.
Rane, R. C.
Ahmad, I.
机构：
[1] Jina Pharmaceut Inc, Libertyville, IL USA
[2] Curie Manavata Canc Ctr, Nasik, India
[3] Mahavir Canc Sansthan, Patna, Bihar, India
[4] Dr Rai Mem Med Ctr, Madras, Tamil Nadu, India
[5] Lions Canc Detect & Treatment Ctr, Surat, India
[6] Lambda Therapeut Res Ltd, Ahmadabad, Gujarat, India
[7] Intas Pharmaceut Ltd, Ahmadabad, Gujarat, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3089
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Erlotinib in combination with capecitabine and docetaxel in patients with metastatic breast cancer: A dose-escalation study
    Twelves, Chris
    Trigo, Jose M.
    Jones, Rob
    De Rosa, Flavio
    Rakhit, Ashok
    Fettner, Scott
    Wright, Tonya
    Baselga, Jose
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (03) : 419 - 426
  • [2] MULTIPLE-DOSE PHARMACOKINETICS OF EPIRUBICIN AT 4 DIFFERENT DOSE LEVELS - STUDIES IN PATIENTS WITH METASTATIC BREAST-CANCER
    JAKOBSEN, P
    STEINESS, E
    BASTHOLT, L
    DALMARK, M
    LORENZEN, A
    PETERSEN, D
    GJEDDE, SB
    SANDBERG, E
    ROSE, C
    NIELSEN, OS
    MOURIDSEN, HT
    JAKOBSEN, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 28 (01) : 63 - 68
  • [3] Dose-escalation phase I study in metastatic breast cancer patients with combination of paclitaxel and tegafur uracil
    Osaki, Akihiko
    Mitsuyama, Shoshu
    Kurebayashi, Jun-Ichi
    Sonoo, Hiroshi
    Nishimura, Reiki
    Koga, Toshihiro
    Murakami, Shigeru
    Ohno, Shinji
    ONCOLOGY LETTERS, 2010, 1 (01) : 45 - 49
  • [4] A phase I dose-escalation study of eribulin and S-1 for metastatic breast cancer
    T Sakiyama
    J Tsurutani
    T Iwasa
    H Kawakami
    Y Nonagase
    T Yoshida
    K Tanaka
    Y Fujisaka
    T Kurata
    Y Komoike
    K Nishio
    K Nakagawa
    British Journal of Cancer, 2015, 112 : 819 - 824
  • [5] A phase I dose-escalation study of eribulin and S-1 for metastatic breast cancer
    Sakiyama, T.
    Tsurutani, J.
    Iwasa, T.
    Kawakami, H.
    Nonagase, Y.
    Yoshida, T.
    Tanaka, K.
    Fujisaka, Y.
    Kurata, T.
    Komoike, Y.
    Nishio, K.
    Nakagawa, K.
    BRITISH JOURNAL OF CANCER, 2015, 112 (05) : 819 - 824
  • [6] Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer
    Kouroussis, C
    Androulakis, N
    Kakolyris, S
    Souglakos, J
    Kotsakis, T
    Mavroudis, D
    Katsogridakis, K
    Vardakis, N
    Hatzidaki, D
    Samonis, G
    Vlachonikolis, J
    Georgoulias, V
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) : 862 - 869
  • [7] A Dose-escalation Study of the Safety and Pharmacology of DAN-222 in Subjects with Metastatic Breast Cancer NCT05261269
    Wright, Ashley P.
    Wyatt, Emily A.
    Hagerty, Timothy
    CANCER RESEARCH, 2023, 83 (05)
  • [8] Dose escalation of cyclophosphamide in patients with breast cancer: Consequences for pharmacokinetics and metabolism
    Kromer, HK
    Busch, FW
    Bohnenstengel, F
    Eichelbaum, M
    Fischer, P
    Opalinska, J
    Schumacher, K
    Schweizer, E
    Busse, D
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PI28 - PI28
  • [9] Dose escalation of cyclophosphamide in patients with breast cancer: Consequences for pharmacokinetics and metabolism
    Busse, D
    Busch, FW
    Bohnenstengel, F
    Eichelbaum, M
    Fischer, P
    Opalinska, J
    Schumacher, K
    Schweizer, E
    Kroemer, HK
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) : 1885 - 1896
  • [10] Open-Label, Dose-Escalation, Phase 1 Study of Safety and Single and Multiple-Dose Pharmacokinetics of Dichlorphenamide in Healthy Volunteers
    Cohen, Fredric
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (01): : 87 - 94
12345